Antibiotic prophylaxis in transurethral surgery.
In a prospective randomized double-blind study, perioperative prophylaxis with cefoperazone, a third-generation cephalosporin, in transurethral surgery was evaluated. Cefoperazone significantly lowered the urinary tract infection rate from 17 per cent to 0 per cent, five to seven days postoperatively. Results from the latest placebo-controlled studies concerning antibiotic prophylaxis in transurethral surgery are summarized, and the use of antibiotic prophylaxis is discussed and recommended.